Effect of methotrexate on embryonal implantation: an experimental rat model

Area of Science:

• Reproductive biology
• Developmental toxicology
• Biochemistry

Background:

• Embryonal implantation is a critical process for pregnancy establishment.
• Glycodelin A (GdA) and Mucin-1 (MUC-1) are key glycoproteins involved in implantation.
• Methotrexate (MTX) is a known teratogen with potential effects on early pregnancy.

Purpose of the Study:

• To investigate the effect of Methotrexate (MTX) on rat embryonal implantation.
• To examine the association between MTX exposure and the expression of Glycodelin A (GdA) and Mucin-1 (MUC-1) during implantation.
• To evaluate MTX's impact on the uterine luminal-glandular-decidualized epithelium.

Main Methods:

• 32 Wistar Albino rats were divided into four groups: control (saline-injected non-pregnant and pregnant) and MTX-treated (saline-injected non-pregnant and pregnant).
• MTX was administered intramuscularly three months prior to pregnancy.
• Uterine horn samples were collected on the 5th day of gestation and analyzed using immunohistochemistry.

Main Results:

• A statistically significant difference in GdA and MUC-1 expression was observed in the uterine luminal-glandular-decidualized epithelium between control and MTX-treated groups.
• MTX exposure was associated with altered expression patterns of GdA and MUC-1.
• These molecular changes suggest a disruption of the implantation process.

Conclusions:

• Methotrexate (MTX) adversely affects key molecular markers (GdA and MUC-1) during rat embryonal implantation.
• The study provides evidence of MTX's detrimental impact on reproductive processes at the molecular level.
• Further research is warranted to understand the full implications of MTX exposure on implantation and early development.